Clinical Trials

Accrual Status
Limit to SWOG Trials

1027 Results

    View
    Status Trial Number Title Activated Closed Accrual Phase Published
    Open S1922 Randomized Phase II Study of Ramucirumab and Paclitaxel versus FOLFIRI in Refractory Small Bowel Adenocarcinoma 12/16/2019 34%
    Open S1827 MRI Brain Surveillance Alone Versus MRI Surveillance and Prophylactic Cranial Irradiation (PCI): A Randomized Phase III Trial in Small-Cell Lung Cancer (MAVERICK) 1/10/2020 32%
    Closed S1900B LUNGMAP S1900B: RET Fustion Positive - LOXO-292 2/10/2020 5%
    Open S1914 A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT versus SBRT Alone in High Risk, Early Stage NSCLC 3/25/2020 74%
    Open S1823 miRNA 371 Study in Germ Cell Tumors 6/1/2020 99%
    Open S1933 A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status 6/15/2020 77%
    Open SLA01 IMMUNE CHECKPOINTS IN GASTRIC CANCER FROM LATIN AMERICAN COUNTRIES 0%
    Open S1904 Decision Support Tool 9/1/2020 96%
    Open S2000 A randomized phase 2 trial of encorafenib + binimetinib + nivolumab vs ipilimumab + nivolumab in BRAFV600-mutant melanoma brain metastases 9/23/2020 91%
    Open S1931 PROBE trial 11/16/2020 28%
    Open S2001 Parallel Randomized Phase II Clinical Trial of Olaparib + Pembrolizumab vs. Olaparib as Maintenance Therapy in Two Cohorts of Metastatic Pancreatic Cancer Patients with DNA Damage Repair Defects 12/4/2020 55%
    Open S1925 EVOLVE CLL 12/14/2020 41%
    Open S2007 Sacituzumab Govitecan for HER2-Neg Breast Cancer and Brain Metastases 12/15/2020 55%
    Open S1900E LUNGMAP S1900E: KRAS Targeted Therapy Sub-Study 4/2/2021 97%
    Open S1937 A Phase III Randomized Trial of Eribulin (NSC #707389) with Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of Metastatic Urothelial Carcinoma Refractory to, or Ineligible for,… 2/16/2021 15%
    Open S1918 Ph II/III study of R-miniCHOP +/- oral aza in elderly with newly diganosed DLBCL 3/19/2021 23%
    Open S2005 A Phase II Randomized Study of Ibrutinib and Rituximab with or without Venetoclax in Previously Untreated Waldenstrom's Macroglobulinemia (WM) / Lymphoplasmacytic Lymphoma (LPL) 6/24/2021 3%
    Open S1912CD CREDIT 7/26/2021 71%
    Open S2013 I-CHECKIT 8/16/2021 100%
    Open S2104 A Phase II Randomized Trial of Postoperative Adjuvant Capecitabine and Temozolimide versus Observation in High-Risk Pancreatic Neuroendocrine Tumors 10/14/2021 28%
    Scroll Table